Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 220

    1.

    The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.

    El-Serag HB, Davila JA, Petersen NJ, McGlynn KA.

    Ann Intern Med. 2003 Nov 18;139(10):817-23. Erratum in: Ann Intern Med. 2004 Jan 20;140(2):151. PMID: 14623619 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Geographic variation within the United States in the incidence of hepatocellular carcinoma.

    Davila JA, Petersena NJ, Nelson HA, El-Serag HB.

    J Clin Epidemiol. 2003 May;56(5):487-93.PMID: 12812824 [PubMed - indexed for MEDLINE]Related articles

    3.

    Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study.

    Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB.

    Gastroenterology. 2004 Nov;127(5):1372-80.PMID: 15521006 [PubMed - indexed for MEDLINE]Related articles

    4.

    Summaries for patients. Increasing rates of primary liver cancer in the United States.

    [No authors listed]

    Ann Intern Med. 2003 Nov 18;139(10):I28. No abstract available. PMID: 14623640 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

    Altekruse SF, McGlynn KA, Reichman ME.

    J Clin Oncol. 2009 Mar 20;27(9):1485-91. Epub 2009 Feb 17.PMID: 19224838 [PubMed - indexed for MEDLINE]Related articles

    6.

    Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.

    El-Serag HB, Davila JA.

    Hepatology. 2004 Mar;39(3):798-803.PMID: 14999699 [PubMed - indexed for MEDLINE]Related articles

    7.

    Rising incidence of hepatocellular carcinoma in the United States.

    El-Serag HB, Mason AC.

    N Engl J Med. 1999 Mar 11;340(10):745-50.PMID: 10072408 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.

    McGlynn KA, Tarone RE, El-Serag HB.

    Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1198-203.PMID: 16775181 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Racial and ethnic variations in hepatocellular carcinoma incidence within the United States.

    Wong R, Corley DA.

    Am J Med. 2008 Jun;121(6):525-31.PMID: 18501235 [PubMed - indexed for MEDLINE]Related articles

    10.

    National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.

    Ahmed F, Perz JF, Kwong S, Jamison PM, Friedman C, Bell BP.

    Prev Chronic Dis. 2008 Jul;5(3):A74. Epub 2008 Jun 15.PMID: 18558024 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Epidemiology of hepatocellular carcinoma.

    el-Serag HB.

    Clin Liver Dis. 2001 Feb;5(1):87-107, vi. Review.PMID: 11218921 [PubMed - indexed for MEDLINE]Related articles

    12.

    Hepatocellular carcinoma: recent trends in the United States.

    El-Serag HB.

    Gastroenterology. 2004 Nov;127(5 Suppl 1):S27-34. Review.PMID: 15508094 [PubMed - indexed for MEDLINE]Related articles

    13.

    Epidemiology of hepatocellular carcinoma in Hispanics in the United States.

    El-Serag HB, Lau M, Eschbach K, Davila J, Goodwin J.

    Arch Intern Med. 2007 Oct 8;167(18):1983-9.PMID: 17923599 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Risk factors for the rising rates of primary liver cancer in the United States.

    El-Serag HB, Mason AC.

    Arch Intern Med. 2000 Nov 27;160(21):3227-30.PMID: 11088082 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

    Shaib YH, Davila JA, McGlynn K, El-Serag HB.

    J Hepatol. 2004 Mar;40(3):472-7.PMID: 15123362 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century.

    Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F; EUROCARE Working Group.

    Am J Gastroenterol. 2007 Aug;102(8):1661-70; quiz 1660, 1671. Epub 2007 Jun 6.PMID: 17555459 [PubMed - indexed for MEDLINE]Related articles

    17.

    The impact of immigration on the increasing incidence of hepatocellular carcinoma in the United States.

    Kulkarni K, Barcak E, El-Serag H, Goodgame R.

    Aliment Pharmacol Ther. 2004 Aug 15;20(4):445-50.PMID: 15298639 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The incidence of hepatocellular carcinoma in US white women with breast cancer after the introduction of tamoxifen in 1977.

    Mühlemann K, Cook LS, Weiss NS.

    Breast Cancer Res Treat. 1994;30(2):201-4.PMID: 7949218 [PubMed - indexed for MEDLINE]Related articles

    19.

    Epidemiology of primary hepatic malignancies in U.S. children.

    Darbari A, Sabin KM, Shapiro CN, Schwarz KB.

    Hepatology. 2003 Sep;38(3):560-6.PMID: 12939582 [PubMed - indexed for MEDLINE]Related articles

    20.

    Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: recent trends.

    Jepsen P, Vilstrup H, Tarone RE, Friis S, Sørensen HT.

    Int J Cancer. 2007 Oct 1;121(7):1624-6.PMID: 17557292 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Recent activity

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...